Factors for Timely Identification of Possible Occurrence of Delirium in Palliative Care: A Prospective Observational Study.


Journal

Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864

Informations de publication

Date de publication:
08 2021
Historique:
received: 19 04 2021
accepted: 01 06 2021
pubmed: 7 7 2021
medline: 7 9 2021
entrez: 6 7 2021
Statut: ppublish

Résumé

Delirium occurs in 50-80% of end-of-life patients but is often misdiagnosed. Identification of clinical factors potentially associated with delirium onset can lead to a correct early diagnosis. To this aim, we conducted a prospective cohort study on patients from an Italian palliative care unit (PCU) admitted in 2018-2019. We evaluated the presence of several clinical factors at patient admission and compared their presence in patients who developed delirium and in those who did not develop it during follow-up. Among 503 enrolled patients, after a median follow-up time of 16 days (interquartile range 6-40 days), 95 (18.9%) developed delirium. Hazard ratios (HR) and corresponding 95% confidence intervals were computed using Cox proportional hazard models. In univariate analyses, factors significantly more frequent in patients with delirium were care in hospice, compromised performance status, kidney disease, fever, renal failure, hypoxia, dehydration, drowsiness, poor well-being, breathlessness, and "around the clock" therapy with psychoactive drugs, particularly haloperidol. In multivariate analyses, setting of care (HR 2.28 for hospice versus home care, 95% CI 1.45-3.60; p < 0.001), presence of breathlessness (HR 1.71, 95% CI 1.03-2.83, p = 0.037), and administration of psychoactive drugs, particularly haloperidol (HR 2.17 for haloperidol, 95% CI 1.11-4.22 and 1.53 for other drugs, 95% CI 0.94-2.48; p = 0.048) were significantly associated with the risk of developing delirium. The study indicates that some clinical factors are associated with the probability of delirium onset. Their evaluation in PC patients could help healthcare professionals to identify the development of delirium in those patients in a timely manner.

Identifiants

pubmed: 34228345
doi: 10.1007/s12325-021-01814-7
pii: 10.1007/s12325-021-01814-7
pmc: PMC8342371
doi:

Banques de données

figshare
['10.6084/m9.figshare.14697003']

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Pagination

4289-4303

Informations de copyright

© 2021. The Author(s).

Références

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edition Washington (DC): American Psychiatric Association. 2013.
Murray AM, Levkoff SE, Wetle TT, et al. Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol. 1993;48:M181–6. https://doi.org/10.1093/geronj/48.5.m181 .
doi: 10.1093/geronj/48.5.m181 pubmed: 8366260
Inouye SK, Westendorp RG, Saczynski JS, Kimchi EY, Cleinman AA. Delirium in elderly people–authors’ reply. Lancet. 2014;383:2045. https://doi.org/10.1016/S0140-6736(14)60994-6 .
doi: 10.1016/S0140-6736(14)60994-6 pubmed: 24931690
Siddiqi N, House AO, Holmes JD. Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age Ageing. 2006;35:350–64. https://doi.org/10.1093/ageing/afl005 .
doi: 10.1093/ageing/afl005 pubmed: 16648149
Brummel NE, Jackson JC, Pandharipande PP, et al. Delirium in the ICU and subsequent long-term disability among survivors of mechanical ventilation. Crit Care Med. 2014;42:369–77. https://doi.org/10.1097/CCM.0b013e3182a645bd .
doi: 10.1097/CCM.0b013e3182a645bd pubmed: 24158172 pmcid: 3947028
Leslie DL, Marcantonio ER, Zhang Y, Leo-Summers L, Inouye SK. One-year health care costs associated with delirium in the elderly population. Arch Intern Med. 2008;168:27–32. https://doi.org/10.1001/archinternmed.2007.4 .
doi: 10.1001/archinternmed.2007.4 pubmed: 18195192 pmcid: 4559525
van den Boogaard M, Schoonhoven L, van der Hoeven JG, van Achterberg T, Pickkers P. Incidence and short-term consequences of delirium in critically ill patients: a prospective observational cohort study. Int J Nurs Stud. 2012;49:775–83. https://doi.org/10.1016/j.ijnurstu.2011.11.016 .
doi: 10.1016/j.ijnurstu.2011.11.016 pubmed: 22197051
Qian X, Russell LB, Valiyeva E, Miller JE. “Quicker and sicker” under Medicare’s prospective payment system for hospitals: new evidence on an old issue from a national longitudinal survey. Bull Econ Res. 2011;63:1–27. https://doi.org/10.1111/j.1467-8586.2010.00369.x .
doi: 10.1111/j.1467-8586.2010.00369.x pubmed: 21141646
Hill TE, Osterweil D, Bakerjian D, Lam A. "Post-Acute Care 2.0" Regarding Burke RE, Whitfield EA, Hittle D, et al. Hospital Readmission From Post-Acute Care Facilities: Risk Factors, Timing, and Outcomes. J Am Med Dir Assoc. 2016;17:368–9. https://doi.org/10.1016/j.jamda.2016.01.009 .
Hey J, Hosker C, Ward J, Kite S, Speechley H. Delirium in palliative care: detection, documentation and management in three settings. Palliat Support Care. 2015;13:1541–5. https://doi.org/10.1017/S1478951513000813 .
doi: 10.1017/S1478951513000813 pubmed: 24139058
Grassi L, Caraceni A, Mitchell AJ, et al. Management of delirium in palliative care: a review. Curr Psychiatry Rep. 2015;17:550. https://doi.org/10.1007/s11920-015-0550-8 .
doi: 10.1007/s11920-015-0550-8 pubmed: 25663153
Breitbart W, Strout D. Delirium in the terminally ill. Clin Geriatr Med. 2000;16:357–72. https://doi.org/10.1016/s0749-0690(05)70061-6 .
doi: 10.1016/s0749-0690(05)70061-6 pubmed: 10783433
Moyer DD. Review article: terminal delirium in geriatric patients with cancer at end of life. Am J Hosp Palliat Care. 2011;28:44–51. https://doi.org/10.1177/1049909110376755 .
doi: 10.1177/1049909110376755 pubmed: 21057140
Watt CL, Momoli F, Ansari MT, et al. The incidence and prevalence of delirium across palliative care settings: a systematic review. Palliat Med. 2019;33:865–77. https://doi.org/10.1177/0269216319854944 .
doi: 10.1177/0269216319854944 pubmed: 31184538 pmcid: 6691600
Lauretani F, Ceda GP, Maggio M, Nardelli A, Saccavini M, Ferrucci L. Capturing side-effect of medication to identify persons at risk of delirium. Aging Clin Exp Res. 2010;22:456–8. https://doi.org/10.1007/BF03324944 .
doi: 10.1007/BF03324944 pubmed: 21422797 pmcid: 6109713
Han JH, Zimmerman EE, Cutler N, et al. Delirium in older emergency department patients: recognition, risk factors, and psychomotor subtypes. Acad Emerg Med. 2009;16:193–200. https://doi.org/10.1111/j.1553-2712.2008.00339.x .
doi: 10.1111/j.1553-2712.2008.00339.x pubmed: 19154565 pmcid: 5015887
Collins N, Blanchard MR, Tookman A, Sampson EL. Detection of delirium in the acute hospital. Age Ageing. 2010;39:131–5. https://doi.org/10.1093/ageing/afp201 .
doi: 10.1093/ageing/afp201 pubmed: 19917632
Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7:6–9.
doi: 10.1177/082585979100700202
Moro C, Brunelli C, Miccinesi G, et al. Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer. 2006;14:30–7. https://doi.org/10.1007/s00520-005-0834-3 .
doi: 10.1007/s00520-005-0834-3 pubmed: 15937688
Bellelli G, Morandi A, Davis DH, et al. Validation of the 4AT, a new instrument for rapid delirium screening: a study in 234 hospitalised older people. Age Ageing. 2014;43:496–502. https://doi.org/10.1093/ageing/afu021 .
doi: 10.1093/ageing/afu021 pubmed: 24590568 pmcid: 4066613
Jeong E, Park J, Lee J. Diagnostic test accuracy of the 4AT for delirium detection: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;17. https://doi.org/10.3390/ijerph17207515 .
Tieges Z, Maclullich AMJ, Anand A, et al. Diagnostic accuracy of the 4AT for delirium detection in older adults: systematic review and meta-analysis. Age Ageing. 2020. https://doi.org/10.1093/ageing/afaa224 .
doi: 10.1093/ageing/afaa224 pubmed: 33196813 pmcid: 8099016
Inouye SK, Foreman MD, Mion LC, Katz KH, Cooney LM Jr. Nurses’ recognition of delirium and its symptoms: comparison of nurse and researcher ratings. Arch Intern Med. 2001;161:2467–73. https://doi.org/10.1001/archinte.161.20.2467 .
doi: 10.1001/archinte.161.20.2467 pubmed: 11700159
Clegg A, Westby M, Young JB. Under-reporting of delirium in the NHS. Age Ageing. 2011;40:283–6. https://doi.org/10.1093/ageing/afq157 .
doi: 10.1093/ageing/afq157 pubmed: 21169280
Steis MR, Fick DM. Are nurses recognizing delirium? A systematic review. J Gerontol Nurs. 2008;34:40–8. https://doi.org/10.3928/00989134-20080901-12 .
doi: 10.3928/00989134-20080901-12 pubmed: 18795564
Setters B, Solberg LM. Delirium. Prim Care. 2017;44:541–59. https://doi.org/10.1016/j.pop.2017.04.010 .
doi: 10.1016/j.pop.2017.04.010 pubmed: 28797379
Prommer E. Role of haloperidol in palliative medicine: an update. Am J Hosp Palliat Care. 2012;29:295–301. https://doi.org/10.1177/1049909111423094 .
doi: 10.1177/1049909111423094 pubmed: 21998445
Crawford GB, Agar MM, Quinn SJ, et al. Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium. J Palliat Med. 2013;16:1335–41. https://doi.org/10.1089/jpm.2013.0230 .
doi: 10.1089/jpm.2013.0230 pubmed: 24138282 pmcid: 3822394
Lindqvist O, Lundquist G, Dickman A, et al. Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion. J Palliat Med. 2013;16:38–43. https://doi.org/10.1089/jpm.2012.0205 .
doi: 10.1089/jpm.2012.0205 pubmed: 23234300
Agar MR, Lawlor PG, Quinn S, et al. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med. 2017;177:34–42. https://doi.org/10.1001/jamainternmed.2016.7491 .
doi: 10.1001/jamainternmed.2016.7491 pubmed: 27918778
Inouye SK. Delirium in older persons. N Engl J Med. 2006;354:1157–65. https://doi.org/10.1056/NEJMra052321 .
doi: 10.1056/NEJMra052321 pubmed: 16540616
Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med. 2000;160:786–94. https://doi.org/10.1001/archinte.160.6.786 .
doi: 10.1001/archinte.160.6.786 pubmed: 10737278
Myrcik D, Statowski W, Trzepizur M, Paladini A, Corli O, Varrassi G. Influence of physical activity on pain, depression and quality of life of patients in palliative care: a proof-of-concept study. J Clin Med. 2021;10:1012. https://doi.org/10.3390/jcm10051012 .
doi: 10.3390/jcm10051012 pubmed: 33801357 pmcid: 7958598
Corli O, Pellegrini G, Bosetti C, et al. Impact of palliative care in evaluating and relieving symptoms in patients with advanced cancer. Results from the DEMETRA study. Int J Env Res Pub Health. 2020;17. https://doi.org/10.3390/ijerph17228429 .

Auteurs

Oscar Corli (O)

Department of Oncology, Pain and Palliative Care Research Unit, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, 20156, Milan, Italy.

Claudia Santucci (C)

Department of Oncology, Laboratory of Methodology for Clinical Research, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, 20156, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milano, Milan, Italy.

Sara Uggeri (S)

Department of Oncology, Pain and Palliative Care Research Unit, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, 20156, Milan, Italy.

Cristina Bosetti (C)

Department of Oncology, Laboratory of Methodology for Clinical Research, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, 20156, Milan, Italy.

Matteo Cattaneo (M)

Palliative Care Unit, ASST Brianza, 20871, Vimercate, MB, Italy.

Daniela Ermolli (D)

Hospice "Fondazione Mantovani", 20093, Cologno Monzese, MI, Italy.

Giustino Varrassi (G)

Paolo Procacci Foundation, Via Tacito 7, 00193, Rome, Italy. giuvarr@gmail.com.

Dariusz Myrcik (D)

Department of Internal Medicine, Medical University of Silesia in Katowice, Piekarska 18, 42-600, Bytom, Poland.

Antonella Paladini (A)

Department of MESVA, University of L'Aquila, 67100, L'Aquila, Italy.

Martina Rekatsina (M)

Whipps Cross Hospital, Barts Health NHS Trust, London, UK.

Cristiana Gerosa (C)

Palliative Care Unit, ASST Brianza, 20871, Vimercate, MB, Italy.

Martina Ornaghi (M)

Palliative Care Unit, ASST Brianza, 20871, Vimercate, MB, Italy.

Alessandra Roccasalva (A)

Palliative Care Unit, ASST Brianza, 20871, Vimercate, MB, Italy.

Paola Santambrogio (P)

Palliative Care Unit, ASST Brianza, 20871, Vimercate, MB, Italy.

Matteo Beretta (M)

Palliative Care Unit, ASST Brianza, 20871, Vimercate, MB, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH